Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Moodys

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Bicine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Bicine?

Bicine is an investigational drug.

There have been 37 clinical trials for Bicine. The most recent clinical trial was a Phase 3 trial, which was initiated on June 30th 2007.

The most common disease conditions in clinical trials are Breast Neoplasms, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Gruppo Italiano Malattie EMatologiche dell'Adulto, Hellenic Oncology Research Group, and University of Cologne.

Recent Clinical Trials for Bicine
TitleSponsorPhase
A Study to Evaluate the Combination of ATX-101 and Platinum-based ChemotherapyNovotech (Australia) Pty LimitedPhase 1/Phase 2
A Study to Evaluate the Combination of ATX-101 and Platinum-based ChemotherapyTHERAPIM PTY LTDPhase 1/Phase 2
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML PatientsChangzhou No.2 People's HospitalPhase 3

See all Bicine clinical trials

Clinical Trial Summary for Bicine

Top disease conditions for Bicine
Top clinical trial sponsors for Bicine

See all Bicine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.